Beta Bionics iLet Bionic Pancreas System Gets FDA Breakthrough Designation |

"Beta Bionics, a firm based in Boston, MA, won Breakthrough Device designation from the FDA for its iLet Bionic Pancreas System, a wearable designed to automatically control blood-sugar levels. Unlike traditional insulin pumps, the iLet doesn’t need any input from the patient about their dietary intake, insulin delivery rates, nor are bolus doses needed to compensate for meals or to correct abnormal levels. The iLet remains an investigational device as..." Lire la suite